🇺🇸 Basal insulin glargine and lixisenatide in United States

Basal insulin glargine and lixisenatide (Basal insulin glargine and lixisenatide) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Basal insulin glargine and lixisenatide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Basal insulin glargine and lixisenatide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Basal insulin glargine and lixisenatide in United States?

LMC Diabetes & Endocrinology Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.